TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Syncom Formu (i) Ltd
SYNCOMF

Syncom Formu (i) Ltd Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 71/100 · Good See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹20.05

Change

+0.02 (0.1%)

Open

₹20.13

Prev. Close

₹20.03

Day High

₹20.4

Day Low

₹19.61

Volume Analysis

Traded

7,105,116

Delivered

1,540,672

Delivery %

21.68%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (56.8%)
  • •Strong 3-year revenue growth (30.0%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹21.22 ₹20.81 ₹20.43 ₹20.02 ₹19.64 ₹19.23 ₹18.85
Fibonacci ₹20.81 ₹20.51 ₹20.32 ₹20.02 ₹19.72 ₹19.53 ₹19.23
Camarilla ₹20.27 ₹20.19 ₹20.12 ₹20.02 ₹19.98 ₹19.91 ₹19.83

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+42.4%

1 Week

+1.01%

1 Month

+3.03%

3 Months

+40.6%

6 Months

+79.5%

1 Year

+20.86%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹8.97

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

20.27%

Net margin 17.27% × asset turnover 0.91x × equity multiplier 1.29x

Company Overview

Sector

Healthcare

Market Cap

₹1,885 Cr

P/E (TTM)

22.0

ROE

17.6%

Book Value

₹4.41

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.

TopFund Analysis

Syncom Formu (i) Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 71/100. The strongest factor is Financial Strength (100/100), while Institutional Ownership (30/100) is the weakest area to weigh before deciding. Strong 3-year EPS growth (56.8%).

TopFund Score — Fundamentals Quality

71/100 — Good

Data confidence: 77/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

100

Growth

100

Valuation

48

Cash Flow

56

Corporate Governance

76

Momentum

79

Institutional Ownership

30

Business Quality

85

Risk & Volatility

39

Liquidity

36

From Screener.in

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Debtor days have improved from 104 to 82.6 days.
  • −Earnings include an other income of Rs.33.1 Cr.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Announcement under Regulation 30 (LODR)-Dividend Updates 26 Sep

Promoters waived ₹4.75 crore final dividend on 47.53 crore shares for FY26.

Closure of Trading Window 24 Sep

Trading window closes from 1 October 2026 until 48 hours after Q2 FY27 results.

Corporate Announcement/Information Under Regulation 42 Of SEBI (LODR) Regulations, 2015 Regarding Record Date. 18 Sep 18 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 08 Sep

Submission of copy of newpaper clippings of notice of 38th Annual General Meeting (AGM), Remote E-Voting, Record Date and other details.

Regulation 36(1)(B) Of The SEBI (LODR) Regulations, 2015- Dispatch Of Letters To Shareholders Who Have Not Registered Their Email Addresses. 07 Sep

38th AGM on 30 Sep 2026; annual report sent to shareholders without registered emails.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 60 64 65 75 87 102 128 149 117 122 115 135 126
Expenses + 53 57 58 65 77 90 113 131 101 103 94 113 99
Operating Profit 6 6 7 9 10 12 15 18 16 18 21 22 26
OPM % 11.0% 10.0% 11.0% 13.0% 12.0% 12.0% 12.0% 12.0% 14.0% 15.0% 18.0% 16.0% 21.0%
Other Income + 2 4 5 3 1 4 4 7 6 5 6 15 8
Interest 1 1 1 1 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 2 2
Profit before tax 6 8 9 10 10 15 17 23 20 22 25 34 32
Tax % 28.0% 23.0% 25.0% 26.0% 24.0% 25.0% 25.0% 24.0% 22.0% 25.0% 25.0% 25.0% 23.0%
Net Profit + 4 7 7 7 8 11 13 18 16 17 19 25 25
EPS in Rs 0 0 0 0 0 0 0 0 0 0 0 0 0
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 115 151 173 184 185 216 222 262 463 488 498
Expenses + 104 135 155 167 168 196 202 232 408 411 410
Operating Profit 11 16 18 17 17 20 20 30 54 77 88
OPM % 9.0% 11.0% 11.0% 9.0% 9.0% 9.0% 9.0% 11.0% 12.0% 16.0% 18.0%
Other Income + 1 1 1 3 3 12 15 14 17 31 33
Interest 1 0 0 0 0 2 3 5 1 1 1
Depreciation 3 3 3 3 3 4 5 5 5 7 7
Profit before tax 8 14 16 16 16 26 27 34 66 101 113
Tax % 33.0% 33.0% 38.0% 36.0% 34.0% 24.0% 24.0% 25.0% 25.0% 24.0% —
Net Profit + 6 9 10 10 11 20 20 25 49 76 86
EPS in Rs 0 0 0 0 0 0 0 0 1 1 1
Dividend Payout % 24.0% 17.0% 16.0% 15.0% 15.0% 13.0% 0.0% 0.0% 0.0% 12.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 65 17 22 31 39 136 162 194 248 321
Borrowings + 2 3 6 6 12 58 83 72 5 1
Other Liabilities + 33 42 31 61 50 28 39 44 67 117
Total Liabilities 123 140 138 175 180 308 378 405 413 534
Fixed Assets + 50 50 46 46 55 94 91 120 125 184
CWIP 0 0 0 5 0 6 26 0 0 0
Investments 7 9 6 23 36 43 64 66 93 109
Other Assets + 66 80 85 101 89 165 197 219 196 241
Total Assets 123 140 138 175 180 308 378 405 413 534
Equity Capital 22 78 78 78 78 86 94 94 94 94

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 6 7 0 24 14 16 11 -6 23 58
Cash from Investing Activity + 0 -4 1 -23 -18 -27 -45 83 -18 -51
Cash from Financing Activity + -6 -1 1 -2 5 8 35 -15 -68 -3
Net Cash Flow -1 2 2 -1 1 -2 1 62 -63 4
CFO/OP 76 66 32 176 108 113 86 7 70 105
Free Cash Flow 3 4 -3 21 2 5 -10 -14 13 46

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 50.57% → 50.57%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 49.44% 49.44% 49.35% 49.34% 49.34% 49.3% 49.32% 49.02% 49.33% 49.17% 49.23% 49.07%
Promoters 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57% 50.57%
FII 0.0% 0.0% 0.08% 0.09% 0.1% 0.13% 0.11% 0.41% 0.1% 0.26% 0.21% 0.35%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Syncom Formu (i) Ltd (this stock) 1,885 22.0 4.54 17.6%
Hester Biosciences Ltd 1,884 35.5 5.24 15.9%
Ngl Fine Chem Limited 1,796 31.4 5.45 17.4%
Suraksha Diagnostic Ltd 1,788 49.9 7.3 14.2%
Krsnaa Diagnostics Ltd 1,785 18.3 1.81 10.9%
Tarsons Products Limited 1,770 150.0 2.8 2.44%
Anlon Healthcare Limited 1,655 52.3 7.18 18.4%

Which Mutual Funds Hold Syncom Formu (i) Ltd?

Frequently Asked Questions about Syncom Formu (i) Ltd

Community Sentiment

What are other investors saying about Syncom Formu (i) Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.